About: Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract Infections

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract Infections Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract Infections (en)
skos:prefLabel	Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract Infections (en)
name	Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract Infections (en)
title	wds:Q64676743-DA7DF7C2-C916-46B1-BD71-32A4E759C4C9
title	A Multicenter, Double-blind, Randomized, Phase 2 Study to Compare the Safety and Efficacy of Intravenous CXA-101 and Intravenous Ceftazidime in Complicated Urinary Tract Infection, Including Pyelonephritis (en)
end time	wds:Q64676743-5273BF8F-2989-4216-A3C6-4A690C91B5EE
end time	2010-02-25 00:00:00Z (xsd:dateTime)
instance of	wds:Q64676743-C281EDAD-5E0C-4DC3-8645-62CA54107353
instance of	clinical trial
start time	wds:Q64676743-4B6D6DA0-EEA3-4578-80A1-B98AB48F4AA7
start time	2009-06-30 00:00:00Z (xsd:dateTime)
country	wds:Q64676743-46544744-6E1F-445B-B72C-005F895029CA wds:Q64676743-B997C783-A6A0-4D7B-9DF3-AD058ABD702B wds:Q64676743-EBA1F794-52DE-4957-84BD-9B0F6207253D
country	Poland United States of America Germany
main subject	wds:Q64676743-3E18466F-1B0C-4AD6-A6CD-61A0B5B1A8E2 wds:Q64676743-EA6D3512-EA74-489B-B2D8-2DF452887319
main subject	pyelonephritis COMPLICATED URINARY TRACT INFECTIONS
research site	wds:Q64676743-49315C74-E498-460D-8765-8A0EA7484C80 wds:Q64676743-C954FE0A-284A-4A36-8F35-DCFFA0976BFF
research site	University of Giessen Compass Research
minimum age	wds:Q64676743-C03A6E04-D6CC-4F01-94F1-106C44B47426
minimum age	18 (xsd:decimal)
medical condition	wds:Q64676743-F50D89DF-B178-4605-987B-85E33895FF70
medical condition	pyelonephritis
number of participants	wds:Q64676743-EB6B138E-9910-4919-9C05-731D3FACA2F6
number of participants	129 (xsd:decimal)
maximum age	wds:Q64676743-2A9C7159-B9EB-4DB2-A08E-D6A99C68598B
maximum age	90 (xsd:decimal)
study type	wds:Q64676743-5B1E923F-0FA9-4858-A562-A230937EE3FF
study type	interventional study
ClinicalTrials.gov ID	wds:Q64676743-702A8243-15DE-44C3-8250-BE275852E6FD
ClinicalTrials.gov ID	NCT00921024
clinical trial phase	wds:Q64676743-EFC524D3-085A-47CC-B329-213E79607183
clinical trial phase	phase II clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q64676743

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software